Delivery Order SPE2DB20D3103-SPE2DB22FL6T6
- Not listed
- This federal contract award is for the delivery of Microgestin FE 1-20 tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,145.70 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on November 17, 2021. The contract has an ultimate completion date of November 18, 2021 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role...
- This federal contract award is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,514.81 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 27, 2023, with a completion date of September 28, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,305.90 firm-fixed-price delivery order is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a prescription medication. The contract award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency (DLA) is for the delivery of pharmaceutical products, including Microgestin FE 1-20 tablets, with a ceiling value of $1,929.72. The contract is a firm fixed-price Delivery Order with a completion date of December 22, 2021. This award is not designated with a set-aside requirement, indicating full and open competition. Amerisourcebergen maintains a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,557.38 firm fixed price delivery order is for the supply of MICROGESTIN FE 1.5-30 TAB 28S, a prescription medication. The award has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- This federal contract award, valued at $1,489.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4554834923 - MICROGESTIN FE 1-20 TABLET 28S. The contract is a firm fixed-price delivery order with a completion date of September 21, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical for a...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $1,456.74. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply MICROGESTIN FE 1.5-30 TAB 28S, a pharmaceutical product. The contract has an ultimate completion date of January 16, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,652.47, is for the delivery of Microgestin FE 1.5-30 tablets (28s). The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025....
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,015.22, is for the delivery of Microgestin FE 1-20 tablets, a hormonal contraceptive medication. The contract has an ultimate completion date of December 18, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the...
- This federal contract award is for the delivery of Microgestin FE 1.5-30 Tab 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price of $1,770.95 and a completion date of July 12, 2022. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FL6T6Delivery Order
This federal contract award is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,288.48 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on November 16, 2021, with a completion date of November 17, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. This specific delivery order is one of many the company receives under that overarching IDC. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 11/16/21 |